SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001493152-21-025228
Filing Date
2021-10-12
Accepted
2021-10-12 17:20:32
Documents
16

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 10239
2 partiiandiii.htm PART II AND III 2062863
3 ex1-1.htm EX1A-1 UNDR AGMT 142874
4 ex1-2.htm EX1A-1 UNDR AGMT 95743
5 ex1-3.htm EX1A-3 HLDRS RTS 14299
6 ex4-1.htm EX1A-4 SUBS AGMT 458202
7 ex11-1.htm EX1A-11 CONSENT 5060
8 ex12-1.htm ADD EXHB 14964
9 form1-a_001.jpg GRAPHIC 10643
10 form1-a_003.jpg GRAPHIC 27637
11 form1-a_004.jpg GRAPHIC 14193
12 form1-a_006.jpg GRAPHIC 14584
13 image_003.jpg GRAPHIC 19053
14 ex1-1_001.jpg GRAPHIC 28087
15 ex1-2_001.jpg GRAPHIC 6174
16 ex1-3_01.jpg GRAPHIC 6174
  Complete submission text file 0001493152-21-025228.txt   2980667
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-A/A | Act: 33 | File No.: 024-11602 | Film No.: 211319404
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences